Novo Nordisk invests $22M in Clayton, NC facility expansion

Novo Nordisk will invest $22 million at its Diabetes Finished Products manufacturing facility in Clayton, North Carolina, creating 22 full-time jobs. The expansion follows a $65 million investment announced ten months earlier.

“Novo Nordisk, which employs almost 1,200 manufacturing workers in Johnston County, will invest $22 million at its Clayton facility, creating 22 full-time jobs.”researchtriangle.org

• 1 source
• researchtriangle.orgDanish Insulin Maker in Johnston County Will Invest $22 Million as BioPharma Crescent Draws Attention - Research Triangle Regional PartnershipDec 4, 2018

Summarized from public sources; check the original articles before acting on it.